Showing 1251-1260 of 5771 results for "".
- Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19’s Impacthttps://modernod.com/news/covid-19-forecasting-the-new-normal/2477626/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19’s impact across eye care and share their predictions for how the current
- Navilas at AAO 2019: Laser is Back with Digital Guidance for Posterior Segment Treatmentshttps://modernod.com/news/navilas-at-aao-2019-laser-is-back-with-digital-guidance-for-posterior-segment-treatments/2476955/At this week’s AAO in San Francisco, OD-OS will be showcasing its Navilas 577s laser platform. The Navilas 577s is a retina laser with integrated eye tracking technology, a transparent workflow, and documentation which proves in clinics and teaching hospitals to be the next generation digital las
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch
- Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Childrenhttps://modernod.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/Thomas Aller, OD, presented updated findings from a prospective clinical trial of NaturalVue (etafilcon A) 1 Day Multifocal Contact Lenses at a briefing for media and industry leaders at the American Academy of Optometry (AAO) Conference in San Antonio on November 9. The NaturalVue portfolio of p
- Non-Contact Panretinal Photocoagulation for Navilas 577s Introduced at AAO 2018https://modernod.com/news/non-contact-panretinal-photocoagulation-for-navilas-577s-introduced-at-aao-2018/2479753/At the AAO 2018 meeting in Chicago, OD-OS is launching a new widefield objective which brings non-contact panretinal photocoagulation with access to the far periphery (ora serrata) to the Navilas 577s Laser System. The new option for peripheral treatments can further enhance compliance of sensiti
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- AOA Honors Leaders in Optometry With 2025 Annual Awardshttps://modernod.com/news/aoa-honors-leaders-in-optometry-with-2025-annual-awards/2487030/The American Optometric Association (AOA), the American Optometric Student Association (AOSA) and The AOA Foundation have announced the recipients of the organizations’ 2025
- American Academy of Optometry Announces 2026 Retina Summit in Indianapolishttps://modernod.com/news/american-academy-of-optometry-announces-2026-retina-summit-in-indianapolis/2486018/The American Academy of Optometry has announced the 2026 Retina Summit, a 1-day continuing education program focused on advancing clinical knowledge and patient care in retinal disease. The event will take place Saturday, April 18, 2026, at the Indianapolis Marriott
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- Nordic Pharma Announces European Launch of Lacrifill Canalicular Gelhttps://modernod.com/news/nordic-pharma-announces-european-launch-of-lacrifill-canalicular-gel/2485691/Nordic Group, the parent company of Nordic Pharma, announced the European launch of Lacrifill, a novel therapy for the management of dry eye disease. Following CE mark approval in April 2025, Lacrifill is now available to healthcare professionals and patients acros